# K160870: Hospira Administration Sets

- Pathway: 510(k) (Special)
- Applicant: Hospira, Inc.
- Decided: Jun 1, 2016 after 63 days
- Product code: FPA (Set, Administration, Intravascular)
- Device class: 2
- Regulation: 21 CFR 880.5440
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 6 generations back to K030467 (2003). 15 ancestors in all.
1 later device descends from it; 1 cites it directly.
1 of 17 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K142367: Hospira Primary Sets, Hospira, Inc. (2014) Summary page 4.
- K143015: Hospira Primary Sets, Hospira, Inc. (2015) Summary page 4.
- K142433: Hospira Extension Set, Hospira, Inc. (2014) Summary page 4.
- K142974: Extension Sets, Hospira, Inc. (2015) Summary page 4.
- K142622: IV Administration, Hospira, Inc. (2015) Summary page 4.
- K143087: Hospira Blood Set, Hospira, Inc. (2015) Summary page 4.

## Most influential descendants
- K192375: Intellifuse Administration and Intellifuse Blood Administration Sets (2020), 0 descendants of its own

## Indications for use
Hospira Primary sets are indicated for the delivery of fluids from a container to a patient’s vascular system. Hospira Extension sets are indicated for the delivery of fluids from a container to a patient's vascular system. Hospira Burette sets are indicated for the delivery of fluids from a container to a patient's vascular system. Hospira Blood sets are indicated for the delivery of fluids including but not limited to blood and blood products from a container to a patients vascular system.

Source page: https://510kreport.com/device/K160870
Methodology: https://510kreport.com/methodology